Elanco ELAN · NYSE
$23.75 +0.83% (+$0.20)
Summary
35 / 100 · Bulios Score
What speaks for it
- It beat profit estimates 7 times in the last 8 quarters.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- Revenue grew by only 2.2% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.6% a year over 5 years. Over the last 3 years it grew by 2.2% a year. For the next fiscal year analysts expect revenue to grow by 8.8%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $199.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 10.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 15
- Hold 4
- Sell 2
Today's price within the analysts' price targets
The average target of $28 is 18% above today's price. 71% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Farm Animal 33%
- Pet Health 32%
- Cattle 16%
- Poultry 12%
- Swine 5.4%
- Other 0.7%
By region
- Non-US 53%
- UNITED STATES 47%
Farm Animal brings in 33% of revenue. Poultry grew fastest, by 6.2% a year.
Segments in detail